Jim Hinkel Senior Director of Financial Planning and Analysis

Australia Database Directory connects you to the industry’s top professionals and even the general public from any country. Besides, our expert team takes great care in creating high-quality databases to help you reach your targets with ease. So, by utilizing our contacts, you can enjoy a significant return on investment in your business. In addition, our service is cost-effective, allowing you to invest only a small amount to see significant gains. Take advantage of our databases to increase customer involvement as well as drive sales in your business. Furthermore, do not hesitate to add our reliable and accurate data to your CRM system today.

Jim Hinkel Senior Director of Financial Planning and Analysis

Rate this post

contact name: Jim Hinkel
contact job function details: financial planning analysis
contact job function: finance

contact job title: Senior Director of Financial Planning and Analysis

contact job seniority: director

contact person city: Ames

contact person state: Iowa

contact person country: United States

contact person zip code:

business name: NewLink Genetics

business domain: newlinkgenetics.com

business facebook URL: https://www.facebook.com/NewLink-Genetics-164976533528812/

business linkedin: http://www.linkedin.com/company/147095

business twitter: https://twitter.com/nlnkgenetics

business website: http://www.newlinkgenetics.com

marketing directors email database

business angellist: http://angel.co/newlink-genetics

business found year: 1999

business city: Ames

business zip code: 50010

business state: Iowa

business country: United States

business language: English

business employee: 104

benjamin reid ceo chief executive officer

business category: biotechnology

business specialty: biotechnology

business technology: google_universal_analytics,css:_max-width,css:_font-size_em,css:_@media,apache,mobile_friendly,wordpress_org,google_font_api,newton_software,omniture_adobe,css:_device_width,asp_net,google_analytics,google_analytics,recaptcha,wordpress_org,google_font_api,mobile_friendly,apache,newton_software

business description: NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics’ IDO pathway inhibitors are designed to harness multiple components of the immune system to combat cancer. Indoximod is being evaluated in combination with treatment regimens including anti-PD-1/PD-L1 agents, cancer vaccines, and chemotherapy across multiple indications such as melanoma, pancreatic cancer and other malignancies.